Report: Still Lots to Learn About GE Crops

A National Academies–led analysis evaluates the impacts of genetically engineered crops—and calls for updated regulations.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Farmers planted nearly 180 million hectares of GE crops worldwide in 2015, the committee reported. PIXABAY, JCESAR2015Members of the National Academies of Sciences, Engineering, and Medicine today (May 17) released a study examining more than three decades of research and commentaries on the environmental, health, social, and economic impacts of genetically engineered (GE) crops. The study authors, which make up the Committee on Genetically Engineered Crops: Past Experience and Future Prospects, also included details on the funders of a given study analyzed and whether it had been peer-reviewed. “This report is intended to provide an independent, objective examination of what has been learned since the introduction of GE crops, based on current evidence,” the group said in a statement.

By and large, the authors noted, it’s too soon to broadly declare the positive and negative impacts of any one GE crop, let alone all of them—which is, of course, what consumers and policy makers asked the group to do.

“We received impassioned requests to give the public a simple, general, authoritative answer about GE crops,” the authors wrote in their report. “Given the complexity of GE issues, we did not see that as appropriate.”

“Once you or I conclude that GE crops are good or bad we look for more evidence to support our previous conclusion,” committee chair Fred Gould, a professor of entomology at North Carolina State University, said in a press release. “I hope that people looking for our report to support ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies